-
May 12, 2026, 3:57 pm109 ptsThe recent Food and Drug Administration (FDA) rejection of RP1, an experimental immunotherapy for advanced melanoma, has sparked frustration among oncologists and patients who see it as another promising therapy kept out of reach. Last month, the agency issued a "complete response…
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.








